Plain-English translation of NCT07666789 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research study that looks back at the medical records of adults with type 1 diabetes who received a second islet transplant after their first one failed. Islet transplants are a specialized treatment where insulin-producing cells from a donor pancreas are placed into your body to help control blood sugar. The study wants to understand how well a second transplant works and whether it's safe to try again after the first one stops working.
Islet transplants can really help people with type 1 diabetes who have severe blood sugar swings and dangerous low blood sugar episodes. However, these transplants don't last forever — over time, the transplanted cells gradually stop working. Doctors don't know much about whether getting a second transplant is worth it or what risks come with it, so this study is gathering information to answer those questions.
You likely qualify if…
You likely don't qualify if…
This is not an experimental treatment study — researchers will review your existing medical records from your transplant care. You won't receive a new medication or procedure as part of this study. The researchers will track your health information at different time points (3 months after your second transplant, at 1 year, and at 5 years) to see how well your second transplant is working and whether you experience any complications.
AI-generated summary from trial data · Jul 7, 2026 · Not medical advice
France